Axxam enters CNS partnership with Lundbeck for Lead Identification
Example single news
Axxam enters CNS partnership with Lundbeck for Lead Identification Read More »
Axxam is proud to announce that Muna Therapeutics, a biotech company founded in 2020 by Aarhus University, financed by Novo Seeds and receiving assets in exchange of equity from Axxam, was successful closing a EUR 60 million (US$ 73 million) Series A financing round today.
Axxam announces its participation in the REsolution consortium, a public-private research partnership supported by the Innovative Medicines Initiative (IMI), to accelerate research in the field of solute carrier (SLC) class of transporters.
Axxam is a member of the REsolution consortium Read More »